Medicine guide

SINETRAV

As listed in the register: SINETRAV 40 microgrammes/mL, collyre en solution

40 microgrammes · collyre en solution

  • Prescription only
Active substance
Travoprost
Made by
HORUS PHARMA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Travoprost). It describes the substance, not this exact product.

Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce IOP by increasing uveoscleral outflow.

The exact mechanism of action is unknown at this time.

Half-life45 min
Mostly cleared after≈ 3.8 hfive half-lives — our arithmetic
How the body breaks it down

Systemically, travoprost free acid is metabolized to inactive metabolites via beta-oxidation of the α (carboxylic acid) chain to give the 1,2-dinor and 1,2,3,4-tetranor analogs, via oxidation of the 15-hydroxyl moiety, as well as via reduction of the 13, 14 double bond.

How it leaves the body

Less than 2% of the topical ocular dose of travoprost was excreted in the urine within 4 hours as the travoprost free acid.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-11-21

Safety of the active substance

From the US prescribing label for the same active substance (Travoprost). It describes the substance, not this exact product.

Most common side effects

Most common adverse reaction (30% to 50%) is conjunctival hyperemia.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made byHORUS PHARMA
Active substanceTravoprost
Strength40 microgrammes
Formcollyre en solution
Routeophtalmique
Dispensing (as stated by the register)liste I
MarketedYes, according to the register
Authorisation procedureProcédure décentralisée
Name in the registerSINETRAV 40 microgrammes/mL, collyre en solution
Packs1 flacon) multidose en polypropylène de 2,5 ml avec système de pompe · Conditionnement multiple (3 x 2,5 ml) : 3 boîtes de 1 flacon multidose en polypropylène de 2,5 ml avec système de pompe
CIS62332319
CIP133400930095706
CIP133400930232828

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.